KBC Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-289,269
| Closed | -$576K | – | 1845 |
|
|
2024
Q3 | $576K | Hold |
289,269
| – | – | ﹤0.01% | 709 |
|
|
2024
Q2 | $1.01M | Hold |
289,269
| – | – | ﹤0.01% | 661 |
|
|
2024
Q1 | $801K | Hold |
289,269
| – | – | ﹤0.01% | 689 |
|
|
2023
Q4 | $492K | Hold |
289,269
| – | – | ﹤0.01% | 746 |
|
|
2023
Q3 | $298K | Hold |
289,269
| – | – | ﹤0.01% | 782 |
|
|
2023
Q2 | $336K | Hold |
289,269
| – | – | ﹤0.01% | 812 |
|
|
2023
Q1 | $437K | Hold |
289,269
| – | – | ﹤0.01% | 800 |
|
|
2022
Q4 | $723K | Hold |
289,269
| – | – | ﹤0.01% | 721 |
|
|
2022
Q3 | $1.22M | Sell |
289,269
-332,964
| -54% | -$1.41M | 0.01% | 641 |
|
|
2022
Q2 | $1.74M | Buy |
622,233
+146,600
| +31% | +$409K | 0.01% | 571 |
|
|
2022
Q1 | $2.72M | Hold |
475,633
| – | – | 0.01% | 522 |
|
|
2021
Q4 | $4.34M | Buy |
475,633
+23,483
| +5% | +$214K | 0.01% | 475 |
|
|
2021
Q3 | $4.83M | Buy |
+452,150
| New | +$4.83M | 0.02% | 479 |
|
|
2019
Q4 | – | Sell |
-550
| Closed | -$10K | – | 1519 |
|
|
2019
Q3 | $10K | Buy |
550
+150
| +38% | +$2.73K | ﹤0.01% | 1459 |
|
|
2019
Q2 | $7K | Hold |
400
| – | – | ﹤0.01% | 1446 |
|
|
2019
Q1 | $10K | Hold |
400
| – | – | ﹤0.01% | 1393 |
|
|
2018
Q4 | $10K | Sell |
400
-100
| -20% | -$2.5K | ﹤0.01% | 1292 |
|
|
2018
Q3 | $16K | Hold |
500
| – | – | ﹤0.01% | 1372 |
|
|
2018
Q2 | $19K | Hold |
500
| – | – | ﹤0.01% | 1268 |
|
|
2018
Q1 | $14K | Hold |
500
| – | – | ﹤0.01% | 1257 |
|
|
2017
Q4 | $9K | Buy |
+500
| New | +$9K | ﹤0.01% | 1249 |
|